| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Xiaoli Zhou CEO | SSE Exchange | CNE100001VG6 ISIN |
| CN Country | 1,686 Employees | 29 May 2026 Last Dividend | 5 May 2016 Last Split | - IPO Date |
Hunan Fangsheng Pharmaceutical Co., Ltd. is a leading player in the pharmaceutical sector in China, engaged in researching, developing, producing, and selling a wide range of pharmaceutical products. Since its inception in 2002, the company has dedicated itself to addressing diverse medical needs across various therapeutic areas. With its headquarters in Changsha, China, Hunan Fangsheng Pharmaceutical has established a significant presence in the Chinese pharmaceutical market, reflecting its commitment to improving health outcomes and contributing to the well-being of communities.
Hunan Fangsheng Pharmaceutical Co., Ltd. offers an extensive portfolio of pharmaceutical products, designed to cater to a broad spectrum of health conditions. Below are some of the key product categories and their intended uses: